4/A//SEC Filing
Fleming Michael 4/A
Accession 0001127602-19-034976
CIK 0000310158other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 11:17 AM ET
Size
6.1 KB
Accession
0001127602-19-034976
Insider Transaction Report
Form 4/AAmended
Fleming Michael
SVP Chief Ethics & Com Officer
Transactions
- Award
Restricted Stock Unit
2019-05-03+4,625→ 4,625 totalFrom: 2020-05-03Exp: 2022-05-03→ Common Stock (4,625 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F2]The original Form 4, filed on May 7, 2019, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the number of restricted stock units granted on May 3, 2019. As a result of this administrative error, the number of restricted stock units granted to the reporting person following the corrected transaction reflects an increase by 3,125 shares in the number of restricted stock units reported.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001772183
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 11:17 AM ET
- Size
- 6.1 KB